α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies

Wong, Yvette C, Krainc, Dimitri·2017·Nature Medicine
DOI 10.1038/nm.4269

Cites (215)

Items 201–215 of 215

  1. Interferon-γ induces progressive nigrostriatal degeneration and basal ganglia calcification
    Paramita Chakrabarty, Carolina Ceballos‐Diaz, Wen-Lang Lin, Amanda Beccard, Karen R. Jansen‐West, Nikolaus R. McFarland, Christopher Janus, Dennis W. Dickson, Pritam Das, Todd Eliot Golde · 2011 · Nature Neuroscience
  2. Active immunization therapies for Parkinson's disease and multiple system atrophy
    Achim Schneeberger, Lanay Tierney, Markus Mandler · 2015 · Movement Disorders
  3. A calcineurin- and NFAT-dependent pathway is involved in -synuclein-induced degeneration of midbrain dopaminergic neurons
    Luo, J., Sun, L., Lin, X., Liu, G., Yu, J., Parisiadou, L., Xie, C., Ding, J., Cai, H. · 2014 · Human Molecular Genetics
  4. Evidence of Native α-Synuclein Conformers in the Human Brain
    Neal S. Gould, Danielle E. Mor, Richard T. Lightfoot, Kristen A. Malkus, Benoit I. Giasson, Harry Ischiropoulos · 2014 · Journal of Biological Chemistry
  5. Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease
    Bidisha Roy, George R. Jackson · 2014 · Human Molecular Genetics
  6. Parkinson's disease: acid‐glucocerebrosidase activity and alpha‐synuclein clearance
    Judith Blanz, Paul Säftig · 2016 · Journal of Neurochemistry
  7. Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
    Elvira Valera, Michael Mante, Scott Anderson, Edward M. Rockenstein, Eliezer Masliah · 2015 · Journal of Neuroinflammation
  8. Unbiased Approaches to Biomarker Discovery in Neurodegenerative Diseases
    Alice S. Chen‐Plotkin · 2014 · Neuron
  9. Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson’s disease
    Edward M. Rockenstein, Jennifer Leigh Clarke, Catherine Viel, Nicholas M Panarello, Christopher M. Treleaven, Changyoun Kim, Brian J. Spencer, Anthony Adame, Hye Jung Park, James C. Dodge et al. · 2016 · Human Molecular Genetics
  10. Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease
    Yvette C. Wong, Dimitri Krainc · 2016 · Movement Disorders
  11. Cofilin 1 activation prevents the defects in axon elongation and guidance induced by extracellular alpha-synuclein
    Sharada M. Tilve, Francesco Difato, Evelina Chieregatti · 2015 · Scientific Reports
  12. Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson’s disease
    Kim, Changyoun, Ojo-Amaize, Emmanuel, Spencer, Brian, Rockenstein, Edward, Mante, Michael, Desplats, Paula, Wrasidlo, Wolf, Adame, Anthony, Nchekwube, Emeka, Oyemade, Olusola et al. · 2015 · Journal of Neuroinflammation
  13. Increased plasma oligomeric alpha-synuclein in patients with lysosomal storage diseases
    С. Н. Пчелина, Евгений Петрович Нужный, Anton Emelyanov, Tatyana Boukina, T. Usenko, Mikhail A. Nikolaev, Galina Salogub, Аndrey F. Yakimovskii, Ekaterina Y Zakharova · 2014 · Neuroscience Letters
  14. Synucleins Antagonize Endoplasmic Reticulum Function to Modulate Dopamine Transporter Trafficking
    Adam W. Oaks, Nicholas Marsh‐Armstrong, Jessica M. Jones, Joel J. Credle, Anita Sidhu · 2013 · PLoS ONE
  15. Development of targeted therapies for Parkinson's disease and related synucleinopathies
    Edmund J. Sybertz, Dimitri Krainc · 2014 · Journal of Lipid Research